What is the fine-grained topic of the following text: The US Food and Drug Administration has accepted for review the firm’s Biologics License Application for the dust mite sublingual allergy immunotherapy (SLIT) tablet, based on data from an extensive clinical development programme involving around 4,400 patients. Only return the topic.
FDA review of firm's Biologics License Application for dust mite allergy treatment